Aricept ODT Dosage
Generic name: DONEPEZIL HYDROCHLORIDE 5mg
Dosage form: tablet, film coated; orally disintegrating tablet
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
ARICEPT should be taken in the evening, just prior to retiring.
ARICEPT can be taken with or without food.
The 23 mg tablet should not be split, crushed or chewed because this may increase its rate of absorption.
Allow ARICEPT ODT to dissolve on the tongue and follow with water.
2.1 Mild to Moderate Alzheimer's Disease
The dosages of ARICEPT shown to be effective in controlled clinical trials are 5 mg and 10 mg administered once per day.
The higher dose of 10 mg did not provide a statistically significantly greater clinical benefit than 5 mg. There is a suggestion, however, based upon order of group mean scores and dose trend analyses of data from these clinical trials, that a daily dose of 10 mg of ARICEPT might provide additional benefit for some patients. Accordingly, whether or not to employ a dose of 10 mg is a matter of prescriber and patient preference.
2.2 Moderate to Severe Alzheimer's Disease
ARICEPT has been shown to be effective in controlled clinical trials at doses of 10 mg and 23 mg administered once daily. Results of a controlled clinical trial in moderate to severe Alzheimer's Disease that compared ARICEPT 23 mg once daily to 10 mg once daily suggest that a 23 mg dose of ARICEPT provided additional benefit.
The recommended starting dose of ARICEPT is 5 mg once daily. Evidence from the controlled trials in mild to moderate Alzheimer's disease indicates that the 10 mg dose, with a one week titration, is likely to be associated with a higher incidence of cholinergic adverse events compared to the 5 mg dose. In open-label trials using a 6 week titration, the type and frequency of these same adverse events were similar between the 5 mg and 10 mg dose groups. Therefore, because ARICEPT steady state is achieved about 15 days after it is started and because the incidence of untoward effects may be influenced by the rate of dose escalation, a dose of 10 mg should not be administered until patients have been on a daily dose of 5 mg for 4 to 6 weeks. A dose of 23 mg once daily can be administered once patients have been on a dose of 10 mg once daily for at least 3 months.